NO890336L - Fremgangsmaate til forbedring av mentale funksjoner. - Google Patents

Fremgangsmaate til forbedring av mentale funksjoner.

Info

Publication number
NO890336L
NO890336L NO89890336A NO890336A NO890336L NO 890336 L NO890336 L NO 890336L NO 89890336 A NO89890336 A NO 89890336A NO 890336 A NO890336 A NO 890336A NO 890336 L NO890336 L NO 890336L
Authority
NO
Norway
Prior art keywords
procedure
mental functions
improving mental
improving
functions
Prior art date
Application number
NO89890336A
Other languages
English (en)
Norwegian (no)
Other versions
NO890336D0 (no
Inventor
Ramon Cacabelos
Francisco Rubia Vila
Thomas Ortiz Alonso
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/148,667 external-priority patent/US4939124A/en
Application filed by Serono Lab filed Critical Serono Lab
Publication of NO890336D0 publication Critical patent/NO890336D0/no
Publication of NO890336L publication Critical patent/NO890336L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Surgery (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Psychiatry (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO89890336A 1988-01-26 1989-01-26 Fremgangsmaate til forbedring av mentale funksjoner. NO890336L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/148,667 US4939124A (en) 1988-01-26 1988-01-26 Treatment and diagnosis of dementia
US07/206,100 US5089472A (en) 1988-01-26 1988-06-13 Use of growth hormone releasing factor for improving mental function

Publications (2)

Publication Number Publication Date
NO890336D0 NO890336D0 (no) 1989-01-26
NO890336L true NO890336L (no) 1989-07-27

Family

ID=26846051

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89890336A NO890336L (no) 1988-01-26 1989-01-26 Fremgangsmaate til forbedring av mentale funksjoner.

Country Status (15)

Country Link
US (1) US5089472A (ko)
EP (1) EP0326381B1 (ko)
JP (2) JP2847098B2 (ko)
KR (1) KR970002484B1 (ko)
CN (1) CN1055641C (ko)
AT (1) ATE106745T1 (ko)
AU (1) AU615714B2 (ko)
CA (1) CA1341017C (ko)
DE (1) DE68915793T2 (ko)
DK (1) DK174866B1 (ko)
FI (1) FI890389A (ko)
IL (1) IL89056A (ko)
NO (1) NO890336L (ko)
RU (1) RU2024261C1 (ko)
UA (1) UA19804A (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6449594A (en) * 1993-04-02 1994-10-24 Ohio University Enhancement of learning and/or memory by a human somatotropin
JP2010539063A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト Ｇｒｆ−１（１−２９）および副腎皮質刺激ホルモン放出因子の、治療剤としての使用
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8318552D0 (en) * 1983-07-08 1983-08-10 Sandoz Ltd Organic compounds
US4747825A (en) * 1984-06-29 1988-05-31 Ferring Laboratories, Inc. Apparatus and methodology for pulsed administration of growth promoting agents
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
US4939124A (en) * 1988-01-26 1990-07-03 Laboratorios Serono S.A. Treatment and diagnosis of dementia

Also Published As

Publication number Publication date
JP2847098B2 (ja) 1999-01-13
KR970002484B1 (en) 1997-03-05
UA19804A (uk) 1997-12-25
JPH10251167A (ja) 1998-09-22
JPH0242025A (ja) 1990-02-13
DE68915793T2 (de) 1995-03-09
EP0326381A3 (en) 1991-08-14
RU2024261C1 (ru) 1994-12-15
EP0326381B1 (en) 1994-06-08
ATE106745T1 (de) 1994-06-15
US5089472A (en) 1992-02-18
AU615714B2 (en) 1991-10-10
CN1036509A (zh) 1989-10-25
IL89056A (en) 1994-07-31
AU2870089A (en) 1989-07-27
EP0326381A2 (en) 1989-08-02
DK31489D0 (da) 1989-01-25
CN1055641C (zh) 2000-08-23
DK174866B1 (da) 2004-01-05
FI890389A0 (fi) 1989-01-26
FI890389A (fi) 1989-07-27
JP2965949B2 (ja) 1999-10-18
KR890011572A (ko) 1989-08-21
NO890336D0 (no) 1989-01-26
DE68915793D1 (de) 1994-07-14
DK31489A (da) 1989-07-27
CA1341017C (en) 2000-06-06
IL89056A0 (en) 1989-08-15

Similar Documents

Publication Publication Date Title
JPS5382089A (en) Attachment for medicine inspirator
DK583087D0 (da) Fremgangsmaade til at foroege glycoproteinstabilitet
DK223190A (da) Afskaermningsskjold til optisk-medicinske indretninger
NO881964D0 (no) Fremgangsmaate til forming av kasselignende rammedeler.
MX9203328A (es) Complejo de interferon de zinc-protamina-alfa.
FI881177A0 (fi) Anordning foer positionering av en patient i en medicinsk panoramaroentgenfotograferingsanordning.
FI875326A0 (fi) Ljusbestraolningsanordning foer medicinal vaord av oera.
NO870866L (no) Fremgangsmÿte for fremstilling av et terapeutisk kombinasjonspreparat.
FI894121A0 (fi) 2-atsa-4-(alkoksikarbonyyli)spiro/4,5/dekan-3-oni
NO890336D0 (no) Fremgangsmaate til forbedring av mentale funksjoner.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
ES2019634B3 (es) Terapia con clorfeniramina.
NO890330D0 (no) Fremgangsmaate til fremstilling av forbindelser med psykotrop virkning.
NO166486C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt peptid.
DK229089D0 (da) Peptid-laegemiddelpraeparater indeholdende alfa-aminoborsyrederivater til indgift via slimhinden
IE791378L (en) Alpha-difluoromethyl amino acids
DE68928670D1 (de) Heterostrukturbipolartransistor
NO892006D0 (no) Anordning for dannelse av oppstaaende kant.
NO863225L (no) Analogifremgangsmaate for fremstilling av et terapeutisk virksomt benzodioxepan.
FI841208A0 (fi) Anordning foer tvaettning av en saengliggande patient.
BR6401450U (pt) Conjunto de frasco-ampola injetor de medicamentos
NO164246C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt antigent peptid.
NO882000D0 (no) Fremgangsmaate til fremstilling av ren dimetyleter.
IT8783509A0 (it) Schermo interno per gallerie.
FI852927L (fi) Foerfarande foer framstaellning av en terapeutiskt anvaendbar 3-metyl-4-klorisoxazol-5-yl-metylenoxiguanidin.